NextPoint Therapeutics Stock

nextpointtx.comHealthcareFounded: 2020

NextPoint Therapeutics is a biotechnology company specializing in new treatments for patients diagnosed with various forms of cancer. Headquartered in Cambridge, Massachusetts, the company leads fieldwork and clinical development on the novel HHLA2 pathway to deliver a new class of monotherapies for patients who may not benefit from other forms of inhibitors.

Register for Details

For more details on financing and valuation for NextPoint Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for NextPoint Therapeutics.

Register Today

NextPoint Therapeutics investors also invested in these private companies

Team

Management Team

XingXing Zang, PhD
Founder
Gordon Freeman, PhD
Founder
Detlev Biniszkiewics, PhD
Chief Executive Officer
Scott Chappel, PhD
Chief Scientific Officer
Paul Conrad, PhD, MBA
Chief Business Officer
Briggs Morrison, MD
Interim Chief Medical Officer

Other companies like NextPoint Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B